Note: Ingredients listed on restricted chemical lists
EC/CAS
57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
>=5-<10 >=5-<10
General Information
Version
2025/03/04
Revision date
2025-09-02
Product name
TECVAYLI Teclistamab drug product
Substance name
TECVAYLI Teclistamab drug product
1.2.1 Relevant identified uses
Large Molecule Pharmaceutical intended for medical use Bispecific/Multispecific antibody
supplier name
Janssen Pharmaceuticals, Inc
Emergency telephone
+16097302000, 1 -800 -424 -9300, +1 703 -741 -5970
Icons in SDS
Company Information
company name
Janssen Pharmaceuticals, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
SDSJanssen@its.jnj.com
Section 2
SECTION 2: Hazards identification
2.2 Label elements
No hazard pictogram, no signal word, no hazard statement(s), no precautionary statement(s) required.
2.3 Other hazards
No serious adverse effect would be expected for healthy individuals who inadv ertently come into contact with the product. As systemic exposure from handling is expected to be negligible in the workplace, hazards from worker exposure is considered unlikely. This product poses low safety risk during human contacts.
2.1 Classification of the substance or mixture
1910.1200) Not a hazardous substance or mixture.
